General Practice Doctors in Saint Peters, MO Accepting Medicare

7 General Practice doctors found. Showing 1 - 7

Mark Robin Geier, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 4101 Mexico Rd, Suite H, Saint Peters, MO 63376 Phone: 636-922-4472

James Edward Jones Sr., D.O. General Practice Medicare: Not Enrolled in Medicare Practice Location: 23 Grant Dr, Saint Peters, MO 63376 Phone: 636-397-0079

Dr. James Timothy Farrell, D.O. General Practice Medicare: Not Enrolled in Medicare Practice Location: 510 Jungermann Rd, Saint Peters, MO 63376 Phone: 636-928-3316

Dr. John L Young, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 4101 Mexico Rd, Suite H, Saint Peters, MO 63376 Phone: 301-989-0548

Jessica Lynn Underhill, DO General Practice Medicare: Accepting Medicare Assignments Practice Location: 6994 Mexico Rd, Saint Peters, MO 63376 Phone: 636-397-3231

Ubaldo R Rodriguez, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 1600 Heritage Lndg, Ste 215, Saint Peters, MO 63303 Phone: 636-939-4200    Fax: 636-939-4204

Dr. Robb R Hicks Iv, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 500 Jungermann Rd Ste 203, Saint Peters, MO 63376 Phone: 314-680-1632    Fax: 888-955-9047

News Archive

eHGT announces eHealth Access Indexing

eHealth Global Technologies, Inc. (eHGT) announces eHealth Access Indexing™. This latest service further simplifies the way physicians obtain clinical records using eHGT's already successful eHealth AccessTM Record Retrieval Service. Having patients' records fully indexed and organized, by date and type of report, and delivered in digital format, saves valuable staff time. This provides physicians the ability to quickly and easily access critical clinical data in minutes instead of hours.

Tolerx publishes follow-up data from study of otelixizumab therapy for new onset T1DM patients

Tolerx, Inc., today announced the publication in Diabetologia, the journal of the European Association for the Study of Diabetes, of the four-year follow-up clinical data from new onset type 1 diabetes (T1DM) patients (age 12-39) who received a single short course of therapy with otelixizumab (ChAglyCD3).

Dendritic cells ensure immune tolerance

One of the most important tasks of the immune system is to identify what is foreign and what is self. If this distinction fails, then the body's own structures will be attacked, the result of which could be an autoimmune disease such as diabetes mellitus type 1 or multiple sclerosis. The only way to protect against these afflictions is to destroy all immune factors that turn against the body's own tissue - in other words: immune tolerance.

Why even presidential pressure might not get more vaccine to market faster

Americans are dying of covid-19 by the thousands, but efforts to ramp up production of potentially lifesaving vaccines are hitting a brick wall.

Read more Medical News

› Verified 5 days ago